These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5217700)

  • 1. [Laboratory investigations on the effect of a heparinoid].
    Harmanci N; Akman N; Ulutin ON
    Rev Med Moyen Orient; 1965; 22(6):541-5. PubMed ID: 5217700
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrocardiographic and rheographic modifications in arteriosclerotics treated with polysulfoester of pentosan (SP-54)].
    Aguglia V; Sgroi C; Cerasola GA
    Boll Soc Ital Cardiol; 1972; 17(2):65-75. PubMed ID: 5071185
    [No Abstract]   [Full Text] [Related]  

  • 3. Preangioplasty fibrinolytic therapy using SP-54 including acute and subacute occlusions.
    Haapanen A; Leinonen A; Seppänen S
    Ann Radiol (Paris); 1984; 27(4):340. PubMed ID: 6204575
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modifications of fibrinolysis and coagulation activity in arteriosclerotic patients treated with a polysulfoester of pentosan (SP-54). I].
    Cajozzo A; Citarrella P; Malleo C
    Boll Soc Ital Cardiol; 1971; 16(3):117-26. PubMed ID: 4110180
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modifications of platelet adhesiveness and aggregation ability in atherosclerotics treated with a polysulfoester of pentosan (SP-54). II].
    Cajozzo A; Citarrella P; Carreca I
    Boll Soc Ital Cardiol; 1971; 16(3):127-34. PubMed ID: 4110181
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modification of periferal diffusion curves with albumin-I 131 at rest and after muscular effort in arteriosclerotics after treatment with polysulfoester of pentosan (SP-54)].
    Indovina I; Licata G; Salerno L
    Boll Soc Ital Cardiol; 1971; 16(4):157-71. PubMed ID: 4110134
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic agents and substances with "minor fibrinolytic" effect].
    Verstraete M; Amery A
    Rev Atheroscler (Paris); 1968; 10(2):21-7. PubMed ID: 5759946
    [No Abstract]   [Full Text] [Related]  

  • 8. [Complex therapy of arteriosclerosis of the lower limbs].
    Bocharov AA; Kohhan EP
    Khirurgiia (Mosk); 1971 Dec; 47(12):37-9. PubMed ID: 5141186
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pyridinol-carbamate and atherosclerosis. Clinical observations and animal experimentation].
    de Oliveira JM
    Hospital (Rio J); 1968 Sep; 74(3):799-806. PubMed ID: 5310119
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activation of the spontaneous fibrinolytic potential in subacute and chronic adnexal and pelvi-peritoneal inflammations with aspecific etiology].
    Della Porta M; Ponte PL; Pacilli L
    Minerva Ginecol; 1965 Nov; 17(22):1099-103. PubMed ID: 5867583
    [No Abstract]   [Full Text] [Related]  

  • 11. On the effectiveness of a combined clarifying-fibrinolytic therapy in the preventive and curative treatment of arteriosclerosis and its sequelae.
    Ferliga G
    G Gerontol; 1966 Jun; 14(6):555-69. PubMed ID: 5989598
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arteriosclerosis and atherogenic drugs].
    Navarrete Pando G
    Angiologia; 1976; 28(1):12-20. PubMed ID: 1008301
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrinolytic factors in atherosclerosis].
    Coccheri S
    Bull Sci Med (Bologna); 1967; 139(4):474-80. PubMed ID: 4236949
    [No Abstract]   [Full Text] [Related]  

  • 14. Arixtra injection. FDA approves synthetic anticlotting drug.
    Nursing; 2002 Mar; 32(3):26. PubMed ID: 11902038
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibrinolytic therapy of arteriosclerosis. Influence on hemocoagulation of a total arterial wall extract for oral use].
    Guglielmi G; Barlattani M; Garbagnati N; Iaschi P; Ciavarelli F
    Clin Ter; 1969 Sep; 50(6):527-36. PubMed ID: 5406050
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA approves synthetic blood thinner.
    FDA Consum; 2002; 36(2):4. PubMed ID: 11989471
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of treatment with the polysulfoester of pentosan (SP 54) on the picture of humoral lipids in arteriosclerosis].
    Natarbartolo A; Di Sciacca A; Campisi D
    Boll Soc Ital Cardiol; 1971; 16(2):83-90. PubMed ID: 5138236
    [No Abstract]   [Full Text] [Related]  

  • 18. Fondaparinux (Arixtra), a new anticoagulant.
    Med Lett Drugs Ther; 2002 May; 44(1130):43-4. PubMed ID: 12011755
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of atherosclerosis].
    Villaverde MM; Sadow HS
    Rev Clin Esp; 1967 Jan; 104(1):67-73. PubMed ID: 5596051
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pyridinol carbamate, a new approach in the prevention and therapy of atherosclerosis].
    Etchevés JC; Buzzi RM; Bruno E; Sacanell C
    Hospital (Rio J); 1968 Sep; 74(3):807-14. PubMed ID: 5310120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.